(redirected from Adrenocortical carcinoma)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia, Wikipedia.
Category filter:
ADCCAntibody-Dependent Cellular Cytotoxicity
ADCCAntibody-Dependent Cell-Mediated Cytotoxicity
ADCCAbu Dhabi Combat Club (wrestling)
ADCCAdenoid Cystic Carcinoma (gland tumor)
ADCCAdvertising and Design Club of Canada (Toronto, Ontario, Canada)
ADCCAlzheimer's Disease Core Center
ADCCAdrenocortical Carcinoma
ADCCAir Defense Control Center
ADCCAvoiding Dangerous Climate Change (conference)
ADCCAutomated Dispensing Cabinet (drug dispensing)
ADCCAsia-Pacific Development Communication Centre (Dhurakij Pundit University; Bangkok, Thailand)
ADCCArctic System Science Data Coordination Center (ARCSS)
ADCCAntibody Dependent Cytotoxic Cell
ADCCAdvanced Data Communication Control
ADCCAir Defense Command & Control
ADCCAsynchronous Data Communications Controller
ADCCAccess Data Consulting Corporation (Greenwood Village, CO)
ADCCAir Defense Coordination Center
ADCCAssociation des Descendants de Capitaines Corsaires (France)
ADCCAbu Dhabi Construction Company (United Arab Emirates)
ADCCAdmiral Drake Cricket Club (UK)
ADCCANZAC (Australian and New Zealand Army Corps) Day Commemoration Committee (Australia)
ADCCAlzheimer's Disease Care Clinic
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
Patients who had adrenocortical carcinoma on final histopathology were included in the study while patients with a benign tumour were excluded.
The radiological findings of different histological components of hemorrhagic pseudocyst and myelolipoma make it difficult to distinguish from adrenocortical carcinomas and other retroperitoneal tumors occupying adrenal region.
As we stated in our study (1), urine steroid profiling has shown that many of the most diagnostic steroids for adrenocortical carcinoma are metabolites of nonhormonally active intermediates.
The prevalence of adrenocortical carcinomas among adrenal incidentalomas ranges from 1.2 to 12% among different studies [5].
Feminizing adrenocortical carcinomas are exceedingly rare in adults and account for 1-2% of adrenocortical carcinomas.
Results of Histopathologic Examination of Adrenal Lesions Adenoma Non-functioning benign adenoma 19 Aldosterone secreting adenoma (Conn's Syndrome) 02 Phaeochromocytoma 04 Adrenocortical carcinoma 03 Cysts Epithelial cyst 02 Endothelial cyst 03 Pseudocyst 06 Parasitic cyst 01
Adrenocortical carcinoma: diagnosis, evaluation and treatment.
* The report provides a snapshot of the global therapeutic landscape of Adrenocortical Carcinoma (Adrenal Cortex Cancer)
Adrenocortical carcinomas from two patients with the p.R337H mutation and six patients without it were selected for gene expression analysis (Supplementary Table S2).
Chapters address the principles, enzymes, and pathways of human steroidogenesis; glucocorticoid action, receptors, and therapy; the secretion and action of aldosterone; adrenal insufficiency; adrenal causes of hypercortisolism; defects of adrenal steroidogenesis; adrenarche and adrenopause; adrenal gland imaging; adrenocortical carcinoma; primary mineralcorticoid excess syndromes and hypertension; mineralcorticoid deficiency; pheochromocytoma; adrenal surgery; and Cushing's syndrome.
To study those interactions, we developed an in vitro co-culture model using H295R human adrenocortical carcinoma (fetal compartment) and BeWo human choriocarcinoma (villous trophoblast compartment) cells.